The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel

Overview of attention for article published in PLOS ONE, September 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,777 followers.

Peripheral neuropathy might be a predictor of failure of chemotherapy with paclitaxel for #BreastCancer https://t.co/iOVZompwMK @PLOSONE https://t.co/6Ir53IrNNX

Reply Repost Favourite

#PLOSONE: The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure ... https://t.co/fz0flCsgYv

Reply Repost Favourite

The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with… https://t.co/6rNaOtYU5u https://t.co/GvgxFxZejS

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.